Description
ORDERING OFFICER EXPRESS REPORT - 7 ORDERS DRUGS
Base award description: EXPRESS REPORT - 82 ORDERING OFFICER DELEGATION ORDERS FOR NCO 18 DRUGS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-07-31+$367,460= $367,460
- Mod 12013-08-01+$32,781= $400,241
- Mod 22013-09-01+$30,556= $430,797
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-07-31 | +$367,460 | $367,460 | EXPRESS REPORT - 82 ORDERING OFFICER DELEGATION ORDERS FOR NCO 18 DRUGS |
| Mod 1· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED) | 2013-08-01 | +$32,781 | $400,241 | ORDERING OFFICER DELEGATION REPORTING - 7 ORDERS - 8/1/13 - 8/31/13 678-V30074 678-V30076 678-V30077 644-A3207… |
| Mod 2· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED) | 2013-09-01 | +$30,556 | $430,797 | ORDERING OFFICER EXPRESS REPORT - 7 ORDERS DRUGS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H5BMHLMMNA28)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0477 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $47,052 | FY2026 |
| 36C24526N0181 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,235 | FY2026 |
| 36C26026F0024 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $65,500 | FY2026 |
| 36C26026F0017 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $406,538 | FY2026 |
| 36C26025F0209 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $197,168 | FY2025 |
| 36C26025F0107 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $70,630 | FY2025 |
Other recipients under 6505 from 258-NETWORK CONTRACT OFFICE 18 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25816P1062 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $18,604 | FY2016 |
| VA25816E1145 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $10,361,853 | FY2016 |
| VA25816P0866 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $27,127 | FY2016 |
| VA25816J0835 | MDD US OPERATIONS, LLC | 258-NETWORK CONTRACT OFFICE 18 | $3,524 | FY2016 |
| VA25816E1024 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $9,829,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA258FY13QTR4ACTELIONPHARMACEUTICALS_3600_VA797BP0414_3600 · retrieved 2026-09-26.